tracken
Aktienkurs
265,13
$
+27,26
11,46 %1 M.
+42,55
19,12 %6 M.
-94,87
26,35 %YTD
-74,29
21,89 %1 J.
+71,30
36,78 %3 J.
+130,56
97,03 %5 J.
+205,77
346,64 %10 J.
Nasdaq,
Schlusskurs Fr, 25.11.2022
Powered by
ISIN
US46120E6023
Symbol
ISRG
Index
Sektor
Industrie
Finanzdaten von Intuitive Surgical
Angaben in Millionen USD.
Intuitive Surgical Aktie News
Seeking Alpha
3 Tage alt
|
Positiv
Intuitive Surgical: Price Hides Great Future Growth
Intuitive Surgical is a great player in the Minimally Invasive Surgery field. Revenue growth and profitability rates underline a great quality company.
Intuitive Surgical is a great player in the Minimally Invasive Surgery field. Revenue growth and profitability rates underline a great quality company.
Forbes
3 Tage alt
|
Neutral
This Robotic Surgical Company Is Likely To Offer Better Returns Over Abbott Stock
We believe Intuitive Surgical stock is currently a better pick than Abbott stock, given its better prospects. Although Abbott is trading at a comparatively lower valuation of 4.1x trailing revenues vs. 15.2x for Intuitive Surgical, this gap in the valuation is justified mainly given the latter's superior revenue growth and lower financial risk, as discussed below.
We believe Intuitive Surgical stock is currently a better pick than Abbott stock, given its better prospects. Although Abbott is trading at a comparatively lower valuation of 4.1x trailing revenues vs. 15.2x for Intuitive Surgical, this gap in the valuation is justified mainly given the latter's superior revenue growth and lower financial risk, as discussed below.
The Motley Fool
17 Tage alt
|
Positiv
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
These innovative stocks have plenty of growth for investors to tap into over the long term.
These innovative stocks have plenty of growth for investors to tap into over the long term.
Firmenprofil
Intuitive Surgical, Inc. beschäftigt sich mit der Entwicklung, Herstellung und Vermarktung von da Vinci Chirurgiesystemen und verwandten Instrumenten und Zubehör für die invasive Chirurgie. Zu seinen Produkten gehören da Vinci und Ion. Das Unternehmen wurde im November 1995 von Frederic H. Moll, John Gordon Freund und Robert G. Younge gegründet und hat seinen Hauptsitz in Sunnyvale, Kalifornien.
| Hauptsitz | USA |
| CEO | Gary Guthart |
| Mitarbeiter | 9.793 |
| Gegründet | 1995 |
| Webseite | www.intuitive.com |
aktien.guide Premium
Mit dem Premium Zugang erhältst Du sämtliche Funktionen von aktien.guide uneingeschränkt mit Realtime-Kursen für 6.931 weltweite Aktien - auf komplett werbefreien Seiten.
* bei jährlicher Zahlung